Isolated cancer cells may lead to personalized treatments

NIH | JULY 31, 2014

Cells shed from tumors enter the bloodstream in very low numbers and circulate through the body. These circulating tumor cells (CTCs) can take root elsewhere, causing the spread of the cancer to other organs, a process called metastasis. As cancers grow and spread, they can undergo genetic mutations that enable them to become resistant to treatment and survive and grow at metastatic sites. The isolation and analysis of CTCs may thus be a useful method for tracking how cancers evolve during therapy.

Circulating tumor cells from the blood of a breast cancer patient. Image by Maria C. Donaldson and Min Yu.

Isolating these rare CTCs from the blood of cancer patients, however, has been a technical challenge. Recently, researchers developed a way to isolate CTCs using microfluidic technology. The microchip device, called the CTC-iChip, enriches CTCs by removing blood cells. As the method doesn’t rely on any cell-surface proteins expressed by tumor cells, it can be applied to virtually all cancers.

In their new study, the research team from Massachusetts General Hospital and Harvard Medical School used the CTC-iChip to establish cell cultures from breast cancer patients.

The scientists collected blood samples from 36 patients with metastatic, estrogen-receptor-positive breast cancers. Using the CTC-iChip, the researchers isolated CTCs from these samples and were able to establish cell lines from 6 of the patients. They found that 3 of 5 tested cell lines formed tumors when injected into mice.

The CTC lines proved to be genetically different than the original tumors. Newly acquired mutations were found in several cancer-associated genes: fibroblast growth factor receptor (FGFR2), PIK3CA, TP53, KRAS, and estrogen receptor (ESR1).

The researchers tested a number of drugs on the cells to find better therapies to treat the cancers. They found that different combinations of drugs were effective against tumors carrying these acquired mutations.

This approach of culturing circulating cancer cells in the blood, analyzing them for new mutations that have developed during therapy, and testing the utility of drugs targeting those mutations could become the essence of individually adjusted cancer therapy in the future.

YOU MAY ALSO LIKE

New research detects Alzheimer's disease markers in nonhuman primates

As a part of their research to understand the evolution of the human brain and how it differs from those of other primates, scientists from Kent State University discovered proteins associated with Alzheimer's disease -- believed to be unique to humans -- in a sample of brains of aged chimpanzees.

Lead in kids’ blood linked with behavioral and emotional problems

Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences.

The Secret Connection between Anxiety, Sleep

Scientists have spotted neurons that play crucial roles in connecting emotions and sleep, shedding light on the future discovery of drug targets for anxiety disorder and/or sleep disorders.

High exposure to radio frequency radiation associated with cancer

The National Toxicology Program concluded there is clear evidence that male rats exposed to high levels of radio frequency radiation like that used in 2G and 3G cell phones developed cancerous heart tumors.

Discovery of RNA transfer through royal jelly could aid development of honey bee vaccines

Researchers have discovered that honey bees are able to share immunity with other bees and to their offspring in a hive by transmitting RNA ‘vaccines’ through royal jelly and worker jelly.

Fruit and veggies pave the road to happiness

A University of Queensland study suggests eating eight or more portions of fruit and vegetables a day not only leads to better physical health but improves mental well-being.